Lung Cancer

apical lung tumor symptoms :: Article Creator Stage 4 Neuroendocrine Small Cell Lung Cancer Neuroendocrine small cell lung cancer (SCLC) occurs when neuroendocrine tumors develop as a result of overactive, cancerous neuroendocrine cells. Stage 4 is extensive stage SCLC. Neuroendocrine cells are specialized cells found in many parts of the body, including the gastrointestinal (GI) tract, gallbladder, and lungs. These cells receive signals from the brain to produce and release certain hormones that control many bodily functions. Neuroendocrine tumors (NETs) develop when neuroendocrine cells become overactive and cancerous. NETs typically involve the GI tract and the lungs. Small cell lung cancer (SCLC), also called oat cell cancer, accounts for 10–15% of all lung cancers. It is also the most prevalent type of neuroendocrine lung tumor. Once a doctor makes a diagnosis, they determine how much the cancer has spread through stagin

pulmonology services :: Article Creator UHS Chenango Memorial Expands Pulmonology Services NORWICH – Respiratory disorders such chronic obstructive pulmonary disease and asthma impact many lives in Chenango County. According to a nurse practitioner who specializes in such illnesses, there are a number of factors that contribute to the prevalence of these long-term lung diseases. "Smoking and tobacco use certainly plays a role, as does environmental exposure," explained Mary Rivera, ANP. "From exposure to mold and mildew to jobs in the building and manufacturing trades, there are many contributing factors that can place someone at risk of developing a respiratory disorder or worsen an existing condition." Often lung disease is an underlying condition that is either undiagnosed or unmanaged, Rivera said. Story Continues Below Adverts Recognizing the unmet need, UHS Chenango Memorial sought to expand pulmonology serv

different stages of breast cancer :: Article Creator What To Know About Triple-negative Breast Cancer Triple-negative breast cancer (TNBC) is a rare type of breast cancer. It is harder to treat and much more aggressive. Because it is aggressive and rare, fewer treatment options are available. It also tends to have a higher rate of recurrence. This form of cancer accounts for around 10–15% of all breast cancer diagnoses. In this article, we look at the risk factors, diagnosis, and available treatments for triple-negative breast cancer. The term triple-negative breast cancer means that cancer cells do not have estrogen or progesterone receptors and do not produce large amounts of human epidermal growth factor receptor 2 (HER2). When diagnosing cancer types, doctors will test for the presence of these receptors and protein production. If all three tests return negative results, a person has triple negative breast cancer. Other

best treatment for non small cell lung cancer :: Article Creator Treatment For Lung Cancer Treating lung cancer used to be simpler — because there simply were not as many treatments available. Today, people facing this disease have more options, and significantly higher survival rates, than they did even a few years ago.  Recent advances allow us to precisely tailor your treatment based on the particular features of your cancer. Newer options mean increased complexity, which is why it's essential to receive care from physicians who specialize in this disease.   At Fred Hutchinson Cancer Center, we have been personalizing lung cancer care for decades. Our experts offer comprehensive care — from prevention, screening and diagnosis to treatment and surveillance. A diagnosis of cancer can feel overwhelming. We have an experienced, compassionate team ready to help.  Dr. Michael Mulligan discusses lung cancer treatment at Fred Hutc

tonsil cancer metastasis to lung :: Article Creator Surviving Stage 4 Lung Cancer: A Personal Story Since then, Ed has worked closely with his care team at the Tampa Moffitt Cancer Center and together they came up with a treatment plan. His healthcare providers decided that Ed would benefit from a three-drug chemotherapy approach. This was because he didn't have an actionable biomarker and targeted therapies weren't an option. Unfortunately, over time the chemotherapy became less effective, so Ed and his oncologist decided to try a Phase One immunotherapy trial. "Both my wife and I were scared. We had young grandchildren and so many things that we wanted to see and do with them. And I was afraid I was going to miss all of that, when chemo stopped working for me." The first clinical trial caused Ed to experience extreme side effects, so he and his oncologist decided to swi